Genzyme Sanofi Canada - Dermatology Update Sponsor

Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world’s leading biotech companies operating in every region of the globe. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.

 Sanofi Genzyme Canada is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Sanofi Genzyme, focuses on rare diseases, multiple sclerosis, oncology, and immunology.

Participant in Dermatology Update 2017:

26oct8:00 am10:00 amThe Future Looks Bright: A New Perspective on Atopic Dermatitis and Emerging TherapiesSANOFI GENZYME Advisory Board8:00 am - 10:00 am The Mackenzie Ballroom I